<DOC>
	<DOCNO>NCT01844583</DOCNO>
	<brief_summary>Safety , tolerability PK concomitant esomeprazole rifampin , QT study single multiple-doses alisertib</brief_summary>
	<brief_title>Safety , Tolerability PK Concomitant Esomeprazole Rifampin , QT Study Single Multiple-doses Alisertib</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Male female patient 18 year old Histologically cytologically confirm metastatic and/or advance solid tumor lymphomas Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 Expected survival longer 3 month enrollment study Female patient post menopausal , surgically sterile , agree practice 2 effective method contraception agree abstain heterosexual intercourse Male patient agree practice effective barrier contraception agree abstain heterosexual intercourse Treatment anticancer therapy investigational agent within 4 week first dose alisertib Known hypersensitivity intolerance rifampin ( patient consider rifampin DDI group ) esomeprazole ( patient consider esomeprazole DDI group ) Recurrent nausea and/or vomit within 14 day first dose alisertib , know GI abnormality GI procedure could interfere modify oral absorption tolerance alisertib Patients require treatment clinically significant enzyme inducer within 14 day first dose alisertib and/or require use medication study A medical condition require use pancreatic enzyme ; daily , chronic , regular use proton pump inhibitor ( PPI ) ; histamine ( H2 ) receptor antagonists Patients require systemic anticoagulation ( exclude lowdose aspirin , lowdose anticoagulation maintain patency venous access device ) . Any cardiovascular condition Female patient lactate positive serum pregnancy test Major surgery within 14 day precede first dose alisertib Lifethreatening uncontrolled medical illness unrelated cancer Newly diagnose uncontrolled cancerrelated central nervous system ( CNS ) disease Autologous stem cell transplant within 3 month Prior allogeneic bone marrow organ transplantation Other severe acute chronic medical psychiatric condition Known suspect human immunodeficiency virus ( HIV ) positive hepatitis B surface antigenpositive status , know suspect active hepatitis C infection Please note additional inclusion exclusion criterion . The study center determine meet criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>